Human Rabies Treatment Market Insights, Global Outlook and Forecast 2022-2028
Human Rabies Treatment Market Insights, Global Outlook and Forecast 2022-2028
The research report on ‘Human Rabies Treatment Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Rabies is a fatal neurological disease, usually spread to humans through the bite of a rabid animal, and it is a persistent global problem.
The latest research study released by Market IntelliX evaluates market size and forecasts of Human Rabies Treatment in Global, including the following market information:
Global Human Rabies Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Human Rabies Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cell Culture Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Rabies Treatment include Biological E Ltd., Cadila Healthcare, Grifols S.A., Kamada Ltd., Kedrion S.p.A., Novartis International AG, Sanofi Pasteur SA and Serum institute of India, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Human Rabies Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Human Rabies Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Human Rabies Treatment Market Segment Percentages, by Type, 2021 (%)
Cell Culture Vaccines
Rabies Immunoglobulin
Nerve Tissue Vaccines
Global Human Rabies Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Human Rabies Treatment Market Segment Percentages, by Application, 2021 (%)
Pre-Exposure Immunization
Post-Exposure Prophylaxis
Global Human Rabies Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Human Rabies Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Rabies Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Human Rabies Treatment revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Biological E Ltd.
Cadila Healthcare
Grifols S.A.
Kamada Ltd.
Kedrion S.p.A.
Novartis International AG
Sanofi Pasteur SA
Serum institute of India
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Human Rabies Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Rabies Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Rabies Treatment Overall Market Size
2.1 Global Human Rabies Treatment Market Size: 2021 VS 2028
2.2 Global Human Rabies Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Rabies Treatment Players in Global Market
3.2 Top Global Human Rabies Treatment Companies Ranked by Revenue
3.3 Global Human Rabies Treatment Revenue by Companies
3.4 Top 3 and Top 5 Human Rabies Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Human Rabies Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Rabies Treatment Players in Global Market
3.6.1 List of Global Tier 1 Human Rabies Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Rabies Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Human Rabies Treatment Market Size Markets, 2021 & 2028
4.1.2 Cell Culture Vaccines
4.1.3 Rabies Immunoglobulin
4.1.4 Nerve Tissue Vaccines
4.2 By Type - Global Human Rabies Treatment Revenue & Forecasts
4.2.1 By Type - Global Human Rabies Treatment Revenue, 2017-2022
4.2.2 By Type - Global Human Rabies Treatment Revenue, 2023-2028
4.2.3 By Type - Global Human Rabies Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Rabies Treatment Market Size, 2021 & 2028
5.1.2 Pre-Exposure Immunization
5.1.3 Post-Exposure Prophylaxis
5.2 By Application - Global Human Rabies Treatment Revenue & Forecasts
5.2.1 By Application - Global Human Rabies Treatment Revenue, 2017-2022
5.2.2 By Application - Global Human Rabies Treatment Revenue, 2023-2028
5.2.3 By Application - Global Human Rabies Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Human Rabies Treatment Market Size, 2021 & 2028
6.2 By Region - Global Human Rabies Treatment Revenue & Forecasts
6.2.1 By Region - Global Human Rabies Treatment Revenue, 2017-2022
6.2.2 By Region - Global Human Rabies Treatment Revenue, 2023-2028
6.2.3 By Region - Global Human Rabies Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Human Rabies Treatment Revenue, 2017-2028
6.3.2 US Human Rabies Treatment Market Size, 2017-2028
6.3.3 Canada Human Rabies Treatment Market Size, 2017-2028
6.3.4 Mexico Human Rabies Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Human Rabies Treatment Revenue, 2017-2028
6.4.2 Germany Human Rabies Treatment Market Size, 2017-2028
6.4.3 France Human Rabies Treatment Market Size, 2017-2028
6.4.4 U.K. Human Rabies Treatment Market Size, 2017-2028
6.4.5 Italy Human Rabies Treatment Market Size, 2017-2028
6.4.6 Russia Human Rabies Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Human Rabies Treatment Market Size, 2017-2028
6.4.8 Benelux Human Rabies Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Human Rabies Treatment Revenue, 2017-2028
6.5.2 China Human Rabies Treatment Market Size, 2017-2028
6.5.3 Japan Human Rabies Treatment Market Size, 2017-2028
6.5.4 South Korea Human Rabies Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Human Rabies Treatment Market Size, 2017-2028
6.5.6 India Human Rabies Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Human Rabies Treatment Revenue, 2017-2028
6.6.2 Brazil Human Rabies Treatment Market Size, 2017-2028
6.6.3 Argentina Human Rabies Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Rabies Treatment Revenue, 2017-2028
6.7.2 Turkey Human Rabies Treatment Market Size, 2017-2028
6.7.3 Israel Human Rabies Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Human Rabies Treatment Market Size, 2017-2028
6.7.5 UAE Human Rabies Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Biological E Ltd.
7.1.1 Biological E Ltd. Corporate Summary
7.1.2 Biological E Ltd. Business Overview
7.1.3 Biological E Ltd. Human Rabies Treatment Major Product Offerings
7.1.4 Biological E Ltd. Human Rabies Treatment Revenue in Global Market (2017-2022)
7.1.5 Biological E Ltd. Key News
7.2 Cadila Healthcare
7.2.1 Cadila Healthcare Corporate Summary
7.2.2 Cadila Healthcare Business Overview
7.2.3 Cadila Healthcare Human Rabies Treatment Major Product Offerings
7.2.4 Cadila Healthcare Human Rabies Treatment Revenue in Global Market (2017-2022)
7.2.5 Cadila Healthcare Key News
7.3 Grifols S.A.
7.3.1 Grifols S.A. Corporate Summary
7.3.2 Grifols S.A. Business Overview
7.3.3 Grifols S.A. Human Rabies Treatment Major Product Offerings
7.3.4 Grifols S.A. Human Rabies Treatment Revenue in Global Market (2017-2022)
7.3.5 Grifols S.A. Key News
7.4 Kamada Ltd.
7.4.1 Kamada Ltd. Corporate Summary
7.4.2 Kamada Ltd. Business Overview
7.4.3 Kamada Ltd. Human Rabies Treatment Major Product Offerings
7.4.4 Kamada Ltd. Human Rabies Treatment Revenue in Global Market (2017-2022)
7.4.5 Kamada Ltd. Key News
7.5 Kedrion S.p.A.
7.5.1 Kedrion S.p.A. Corporate Summary
7.5.2 Kedrion S.p.A. Business Overview
7.5.3 Kedrion S.p.A. Human Rabies Treatment Major Product Offerings
7.5.4 Kedrion S.p.A. Human Rabies Treatment Revenue in Global Market (2017-2022)
7.5.5 Kedrion S.p.A. Key News
7.6 Novartis International AG
7.6.1 Novartis International AG Corporate Summary
7.6.2 Novartis International AG Business Overview
7.6.3 Novartis International AG Human Rabies Treatment Major Product Offerings
7.6.4 Novartis International AG Human Rabies Treatment Revenue in Global Market (2017-2022)
7.6.5 Novartis International AG Key News
7.7 Sanofi Pasteur SA
7.7.1 Sanofi Pasteur SA Corporate Summary
7.7.2 Sanofi Pasteur SA Business Overview
7.7.3 Sanofi Pasteur SA Human Rabies Treatment Major Product Offerings
7.7.4 Sanofi Pasteur SA Human Rabies Treatment Revenue in Global Market (2017-2022)
7.7.5 Sanofi Pasteur SA Key News
7.8 Serum institute of India
7.8.1 Serum institute of India Corporate Summary
7.8.2 Serum institute of India Business Overview
7.8.3 Serum institute of India Human Rabies Treatment Major Product Offerings
7.8.4 Serum institute of India Human Rabies Treatment Revenue in Global Market (2017-2022)
7.8.5 Serum institute of India Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Human Rabies Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|